In our previous study, we had found that WYHZTL formula could inhibit TGF-β/smad signaling pathway, thereby inhibiting collagen expression in SSc skin fibroblasts and exerting anti-fibrosis effect [30]. The gene discussed is TGFB1; the disease is systemic sclerosis.